论文部分内容阅读
小剂量阿糖胞苷(LD-Ara-c)治疗急性粒细胞白血病(AGL)的效果,临床报道缓解率约在0.50～0.70左右。1985年11月至1986年11月,我们设计以LD-Ara-c加柔红霉素组成AD方案治疗AGL患者20例。现将结果报道并分析如下: 材料与方法本文20例AGL患者均为临床和血液学检查并按1986年天津召开的白血病分类分型讨论会而确诊者,年龄14～58岁,(平均35.4岁),男12例,女8例。用药方法:阿糖胞苷用量为每次10mg/
Small doses of cytarabine (LD-Ara-c) in the treatment of acute myeloid leukemia (AGL) effect, clinical coverage rate of about 0.50 to 0.70 or so. From November 1985 to November 1986, we designed 20 patients with AGL treated with LD regimen consisting of LD-Ara-c and daunorubicin. The results are reported and analyzed as follows: Materials and Methods In this paper, 20 patients with AGL were clinically and hematologically examined according to the classification of leukemia held in Tianjin in 1986, the type of diagnosis meeting, aged 14 to 58 years (mean 35.4 years ), 12 males and 8 females. Medication: Cytarabine dosage for each 10mg /